Published in Ann Intern Med on May 15, 2001
Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav (2006) 8.11
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med (2002) 5.30
Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS (2004) 5.04
Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology (2002) 4.67
A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49
Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med (2004) 4.17
Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr (2006) 3.93
A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol (2009) 3.26
Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA (2011) 3.25
Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav (2007) 2.98
Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep (2005) 2.97
Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med (2005) 2.71
Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol (2007) 2.62
Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav (2007) 2.20
Suboptimal adherence to doxycycline and treatment outcomes among men with non-gonococcal urethritis: a prospective cohort study. Sex Transm Infect (2013) 2.16
Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS (2011) 2.11
Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS (2014) 2.10
Improving on a coin toss to predict patient adherence to medications. Ann Intern Med (2001) 2.06
The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One (2012) 2.05
Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials (2008) 2.01
Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol (2012) 1.94
Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr (2007) 1.91
A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr (2006) 1.85
How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med (2002) 1.84
A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care (2013) 1.81
Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study. PLoS One (2010) 1.79
Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care (2008) 1.77
Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis (2011) 1.77
Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr (2008) 1.70
Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics (2008) 1.68
Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav (2010) 1.60
Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med (2002) 1.58
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Arch Intern Med (2009) 1.54
Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev (2009) 1.54
Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure. AIDS (2012) 1.52
Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa. AIDS Res Treat (2012) 1.51
A proposal for quality standards for measuring medication adherence in research. AIDS Behav (2013) 1.51
Predictors of adherence to glaucoma treatment in a multisite study. Ann Behav Med (2015) 1.48
A single-item self-report medication adherence question predicts hospitalisation and death in patients with heart failure. J Clin Nurs (2013) 1.48
Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients. J Gen Intern Med (2004) 1.47
Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol (2007) 1.46
Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS (2012) 1.42
Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav (2013) 1.41
Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med (2004) 1.41
How qualitative methods contribute to understanding combination antiretroviral therapy adherence. J Acquir Immune Defic Syndr (2006) 1.39
The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy. AIDS Care (2006) 1.39
Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research. Clin Child Fam Psychol Rev (2003) 1.35
Importance of dose timing to achieving undetectable viral loads. AIDS Behav (2009) 1.35
Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol (2008) 1.32
Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. J Gen Intern Med (2003) 1.30
Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med (2008) 1.30
Knowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child-transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional study. BMC Womens Health (2013) 1.29
Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study. J Acquir Immune Defic Syndr (2010) 1.27
How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? HIV Clin Trials (2008) 1.25
Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial. J Infect Dis (2012) 1.25
Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr (2010) 1.24
Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J Behav Med (2010) 1.24
Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse. AIDS Behav (2006) 1.22
Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res (2010) 1.22
Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators. BMC Health Serv Res (2010) 1.20
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial. AIDS (2010) 1.20
Supporting children to adhere to anti-retroviral therapy in urban Malawi: multi method insights. BMC Pediatr (2009) 1.17
The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes. J Acquir Immune Defic Syndr (2008) 1.16
Medication Adherence Measures: An Overview. Biomed Res Int (2015) 1.16
Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya. J Acquir Immune Defic Syndr (2014) 1.16
Relationship of prospective memory to neuropsychological function and antiretroviral adherence. Arch Clin Neuropsychol (2009) 1.15
Patient-clinician relationships and treatment system effects on HIV medication adherence. AIDS Behav (2005) 1.14
MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav (2013) 1.14
A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA. AIDS Care (2009) 1.14
Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics. Contemp Clin Trials (2009) 1.13
Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting. AIDS (2012) 1.13
How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag (2007) 1.12
Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Behav (2007) 1.11
Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients. HIV Clin Trials (2011) 1.10
Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav (2013) 1.09
Livelihood security and adherence to antiretroviral therapy in low and middle income settings: a systematic review. PLoS One (2011) 1.09
Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research. Aliment Pharmacol Ther (2009) 1.08
Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients' beliefs about the medicine. A prospective cohort study. Rheumatol Int (2009) 1.08
A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Serv Res (2011) 1.08
Utilization of medical treatments and adherence to antiretroviral therapy among HIV-positive adults with histories of childhood sexual abuse. AIDS Patient Care STDS (2009) 1.07
HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav (2012) 1.06
Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health (2013) 1.06
Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care (2010) 1.05
Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates. Addict Behav (2007) 1.05
Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study. Afr Health Sci (2009) 1.03
Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Type 2 Diabetes. J Cogn Psychother (2010) 1.03
Symptoms of depression and anxiety and adherence to antihypertensive medication. Am J Hypertens (2012) 1.03
Relationship of race-, sexual orientation-, and HIV-related discrimination with adherence to HIV treatment: a pilot study. J Behav Med (2008) 1.03
Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin. Aliment Pharmacol Ther (2008) 1.02
Modeling and simulation of adherence: approaches and applications in therapeutics. AAPS J (2005) 1.02
Clinic Attendance for Medication Refills and Medication Adherence amongst an Antiretroviral Treatment Cohort in Uganda: A Prospective Study. AIDS Res Treat (2010) 1.02
The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. Contemp Clin Trials (2014) 1.02
Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence. AIDS Behav (2008) 1.01
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women. Antimicrob Agents Chemother (2009) 1.01
Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment. AIDS Behav (2013) 1.01
Improving HIV/AIDS care through treatment advocacy: going beyond client education to empowerment by facilitating client-provider relationships. AIDS Care (2011) 1.01
Access to antiretroviral therapy for adults and children with HIV infection in developing countries: Horizons studies, 2002-2008. Public Health Rep (2010) 1.01
Rethinking adherence: a health literacy-informed model of medication self-management. J Health Commun (2013) 1.00
The MOS short-form general health survey. Reliability and validity in a patient population. Med Care (1988) 21.00
The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA (1989) 12.07
Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA (1989) 11.97
Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol (2001) 10.35
The contributions of authors to multiauthored biomedical research papers. JAMA (1994) 9.95
Antibiotic susceptibility patterns as aids in classification and characterization of gram-negative anaerobic bacilli. J Bacteriol (1967) 5.67
Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol (1998) 5.64
Are Latinos less satisfied with communication by health care providers? J Gen Intern Med (1999) 5.26
Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol (1993) 5.13
The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc (2001) 4.99
Quality-of-life outcomes in men treated for localized prostate cancer. JAMA (1995) 4.69
Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment. Ann Intern Med (1997) 4.56
Methods for measuring patient satisfaction with specific medical encounters. Med Care (1988) 4.38
The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care (1998) 4.34
The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J Virol (1994) 3.95
Differences in CAHPS adult survey reports and ratings by race and ethnicity: an analysis of the National CAHPS benchmarking data 1.0. Health Serv Res (2001) 3.62
A health-related quality of life measure for multiple sclerosis. Qual Life Res (1995) 3.46
A comparative review of generic quality-of-life instruments. Pharmacoeconomics (2000) 3.42
Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med (1992) 3.38
Lincomycin: activity against anaerobes and effect on normal human fecal flora. Antimicrob Agents Chemother (Bethesda) (1965) 3.29
The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25
Metabolism of reduced methylated sulfur compounds in anaerobic sediments and by a pure culture of an estuarine methanogen. Appl Environ Microbiol (1986) 3.25
Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial. JAMA (2000) 3.13
Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study. JAMA (1989) 2.79
Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res (1997) 2.75
Selenate reduction to elemental selenium by anaerobic bacteria in sediments and culture: biogeochemical significance of a novel, sulfate-independent respiration. Appl Environ Microbiol (1989) 2.74
Racial and ethnic differences in parents' assessments of pediatric care in Medicaid managed care. Health Serv Res (2001) 2.68
Managed care and capitation in California: how do physicians at financial risk control their own utilization? Ann Intern Med (1995) 2.64
Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization. J Acquir Immune Defic Syndr (2000) 2.60
CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.45
Antidepressants and cancer: cause for concern? J Clin Psychopharmacol (1993) 2.43
Self-study from web-based and printed guideline materials. A randomized, controlled trial among resident physicians. Ann Intern Med (2000) 2.40
End-of-life decision making: a qualitative study of elderly individuals. J Gen Intern Med (2000) 2.37
Evaluation of the research norms of scientists and administrators responsible for academic research integrity. JAMA (1998) 2.30
Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA (2000) 2.26
Life-sustaining treatment decisions for nursing home residents: who discusses, who decides and what is decided? J Am Geriatr Soc (1999) 2.25
A randomized trial of the use of patient self-assessment data to improve community practices. Eff Clin Pract (1999) 2.24
In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J Virol (1996) 2.22
Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). J Bacteriol (1967) 2.21
Value of functional status as a predictor of mortality: results of a prospective study. Am J Med (1992) 2.15
Isolation, Growth, and Metabolism of an Obligately Anaerobic, Selenate-Respiring Bacterium, Strain SES-3. Appl Environ Microbiol (1994) 2.13
Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences. AIDS Care (2005) 2.12
Case-mix adjustment of the National CAHPS benchmarking data 1.0: a violation of model assumptions? Health Serv Res (2001) 2.10
Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect (2009) 2.04
Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med (1993) 2.03
Do consumer reports of health plan quality affect health plan selection? Health Serv Res (2000) 2.03
The functional status of patients. How can it be measured in physicians' offices? Med Care (1990) 2.03
Arsenic(III) fuels anoxygenic photosynthesis in hot spring biofilms from Mono Lake, California. Science (2008) 1.98
Amoxicillin prophylaxis in oral surgery. Rev Stomatol Chir Maxillofac (2012) 1.97
Confirmatory factor analysis of the Consumer Assessment of Health Plans Study (CAHPS) 1.0 Core Survey. Psychol Assess (2001) 1.96
Development of the quality of life in epilepsy inventory. Epilepsia (1995) 1.93
Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry (2000) 1.90
Relationship of body mass index to subsequent mortality among seriously ill hospitalized patients. SUPPORT Investigators. The Study to Understand Prognoses and Preferences for Outcome and Risks of Treatments. Crit Care Med (1997) 1.89
Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett (1996) 1.87
A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care (1992) 1.84
The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol (1995) 1.82
Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol (1995) 1.82
Assessing care of vulnerable elders: methods for developing quality indicators. Ann Intern Med (2001) 1.77
Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest (1982) 1.76
Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1999) 1.74
Sedation and analgesia for colonoscopy: patient tolerance, pain, and cardiorespiratory parameters. Gastrointest Endosc (1997) 1.74
Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates. Appl Environ Microbiol (1996) 1.72
Ataxia and slurred speech after artesunate treatment for falciparum malaria. N Engl J Med (1997) 1.72
Developing quality indicators for older adults: transfer from the USA to the UK is feasible. Qual Saf Health Care (2004) 1.72
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Primary care physicians' satisfaction with quality of care in California capitated medical groups. JAMA (1997) 1.68
Evaluating the equivalence of health care ratings by whites and Hispanics. Med Care (2000) 1.65
Respiratory rate measurement in adults--how reliable is it? Respir Med (2002) 1.64
Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study. Qual Life Res (2000) 1.63
Stepping through the drug use sequence: longitudinal scalogram analysis of initiation and regular use. J Abnorm Psychol (1992) 1.62
White paper on herbal products. American College of Clinical Pharmacy. Pharmacotherapy (2000) 1.58
Clamping breath alcohol concentration reduces experimental variance: application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcohol Clin Exp Res (1998) 1.58
Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med (2001) 1.57
The physician and employee judgment system: reliability and validity of a hospital quality measurement method. QRB Qual Rev Bull (1992) 1.56
The North Coast Cholesterol Check Campaign. Results of the first three years of a large-scale public screening programme. Med J Aust (1991) 1.56
Factors associated with change in resuscitation preference of seriously ill patients. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Arch Intern Med (1996) 1.56
Alcohol-related problems in older persons. Determinants, consequences, and screening. Arch Intern Med (1996) 1.56
Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.55
Quality of life measures in epilepsy: how well can they detect change over time? Neurology (2000) 1.54
Degradation of methyl bromide by methanotrophic bacteria in cell suspensions and soils. Appl Environ Microbiol (1994) 1.54
Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0. Am J Gastroenterol (2000) 1.53
Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis (1995) 1.53
Neuralgia-inducing cavitational osteonecrosis (NICO). Osteomyelitis in 224 jawbone samples from patients with facial neuralgia. Oral Surg Oral Med Oral Pathol (1992) 1.53
Bacterial oxidation of methyl bromide in fumigated agricultural soils. Appl Environ Microbiol (1997) 1.53
Measuring physical function in community-dwelling older persons: a comparison of self-administered, interviewer-administered, and performance-based measures. J Am Geriatr Soc (1995) 1.52
Dissimilatory arsenate and sulfate reduction in sediments of two hypersaline, arsenic-rich soda lakes: Mono and Searles Lakes, California. Appl Environ Microbiol (2006) 1.52
Identifying a short functional disability screen for older persons. J Gerontol A Biol Sci Med Sci (2000) 1.51
Effects of cost sharing on care seeking and health status: results from the Medical Outcomes Study. Am J Public Health (2001) 1.49
Patients with methicillin-resistant Staphylococcus aureus infection: twenty-first century lepers. J Hosp Infect (2010) 1.48
The prospective effect of access to medical care on health-related quality-of-life outcomes in patients with symptomatic HIV disease. Med Care (1998) 1.47
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults. JAMA (1999) 1.46
Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J Clin Invest (1994) 1.46
Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Mov Disord (1989) 1.44
Acove quality indicators. Ann Intern Med (2001) 1.44
The new Labcor-Santiago pericardial bioprosthesis. J Card Surg (1991) 1.43
Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Med Care (1995) 1.43